Maladies peptiques [Progress in 2008 for acid related diseases]

Details

Serval ID
serval:BIB_46E5D698B7F2
Type
Article: article from journal or magazin.
Collection
Publications
Institution
Title
Maladies peptiques [Progress in 2008 for acid related diseases]
Journal
Revue Médicale Suisse
Author(s)
Jornod P., Vouillamoz D., Viani F., Nichita C., Dorta G.
ISSN
1660-9379
Publication state
Published
Issued date
2009
Volume
5
Number
187
Pages
167-175
Language
french
Abstract
The treatment of reflux disease did not change in the review period. PPI therapy remains the first line treatment and surgery the second line approach. Endoscopic anti-reflux procedures should be only performed in controlled studies. Beside the classic triple therapy, sequential treatment of Helicobacter pylori infection can today be considered as a first line therapy. PPI are effective in the prevention of gastroduodenal lesions and in the treatment of dyspeptic symptoms induced by NSAIDs treatment. Only patients younger then 65 years and without any risk factors do not need a preventive PPI prescription during classic NSAIDS treatment.
Keywords
Anti-Ulcer Agents, Digestive System Surgical Procedures, Gastroesophageal Reflux, Helicobacter Infections, Humans, Proton Pump Inhibitors
Pubmed
Create date
17/04/2009 18:08
Last modification date
20/08/2019 13:52
Usage data